|
FY2020
12 months to May 31, 2020
|
|
|---|---|
| Cash used in operating activities: | |
| Net loss for the year | |
| Adjustments for: | |
| Future income taxes | |
| Fair value adjustment on sale of inventory | |
| Fair value adjustment on growth of biological assets | |
| Loss on marketable securities | |
| Unrealized foreign exchange gain | |
| Amortization | |
| Loss (gain) on sale of capital assets | |
| Impairment | |
| Unrealized loss on convertible notes receivable | |
| Loss on promissory notes receivable | |
| Other non-cash items | |
| Share-based compensation | |
| Loss (gain) on long-term investments | |
| Gain on convertible debentures | |
| Change in non-cash working capital | |
| Cash flows from (used in) operating activities | |
| Cash provided by (used in) financing activities: | |
| Share capital issued, net of cash issuance costs | |
| Proceeds from warrants and options exercised | |
| Repayment of convertible debentures | |
| Proceeds from long-term debt | |
| Repayment of long-term debt | |
| Repayment of lease liabilities | |
| Increase in bank indebtedness | |
| Cash flows from (used in) financing activities | |
| Cash used in investing activities: | |
| Proceeds from disposal of marketable securities | |
| Investment in capital and intangible assets | |
| Proceeds from disposal of capital assets | |
| Repayment of convertible and promissory notes receivable | |
| Investment in long-term investments and equity investees | |
| Proceeds from disposal of long-term investments and equity investees | |
| Net cash paid on business acquisitions | |
| Cash flows from (used in) investing activities | |
| Net increase (decrease) in cash and cash equivalents | |
| Cash and cash equivalents, beginning of year | |
| Cash and cash equivalents, end of year |
Loading...
